Platform / Five modules

One editor system.

One platform, five modules, every program. Precision defines the write, fidelity proves it, control gates it, manufacture produces it, and delivery aims it. Walk the index; the modules scroll.

03 / Platform

Five modules. One editor system.

Every B1rde program runs the same five-module system: precision defines the write, fidelity proves it, control gates it, manufacture produces it, delivery aims it.

Precision

Single-nucleotide resolution, no double-strand breaks.

B1rde editors write one base at a time inside a twelve-nucleotide address window. There is no double-strand break, no donor template, and no scramble of indels to sequence around. The edit lands where it is addressed, or the program does not ship.

White laboratory microscope on a clean bench in even light
Fig. 01 / Editor characterization bench
Address window
12 nt
Indel rate
<0.01%
On-target concordance
94.7%
Double-strand break
None

Fidelity

Off-target events designed out, then sequenced out.

Every guide set passes an off-target funnel: a structural model, a whole-transcriptome screen, and empirical capture sequencing. Programs are released only when thirty gigabases of whole-genome data show no off-target event above the detection limit.

Abstract geometric composition of hard edges in light and shadow
Fig. 02 / Address maps, rendered
Whole-genome screen
30 Gb per program
Detected off-targets
Below LOD
Guide redundancy
3x overlapping set
Address mismatch rate
<0.1%

Control

Activity gated to the tissue that needs it.

Editor activity is gated. A tissue-specific promoter decides where the machinery may run, a destabilizing domain sets how long it lives, and a small-molecule switch can end expression early. Exposure is measured in hours, not weeks.

Expression gate
Tissue-specific promoter
Reversibility
Small-molecule shutoff
Dose ramp
4 log range
Expression window
<72 h

Manufacture

GMP editors, synthesized to specification.

Editors are produced as GMP mRNA and guide RNA with a twelve-assay release panel and full batch genealogy. Process analytical technology targets a three percent coefficient of variation on every batch.

Minimal laboratory glassware arranged on a white surface
Fig. 03 / Release analytics
Format
mRNA plus guide RNA
Release panel
12 QC assays
Batch consistency
CV <3%
Lead time
6 weeks

Delivery

In-vivo targeting, no ex-vivo handling.

Targeted lipid nanoparticles and engineered capsids address tissue by receptor, so the edit is delivered where it is needed. No ex-vivo handling, no conditioning chemotherapy, one infusion on an outpatient schedule by design.

Modern clinical treatment room with clean surfaces and daylight
Fig. 04 / Dosing suite
Vectors
LNP plus AAV capsid panel
Tropism
Hepatocyte, muscle, CNS
Ex-vivo handling
None
Schedule
Single infusion

Specification sheet complete.